Pharmacy Benefit Caps And The Chronically Ill
Open Access
- 1 September 2007
- journal article
- research article
- Published by Health Affairs (Project Hope) in Health Affairs
- Vol. 26 (5), 1333-1344
- https://doi.org/10.1377/hlthaff.26.5.1333
Abstract
In this paper we examine medication use among retirees with employer-sponsored drug coverage both with and without annual benefit limits. We find that pharmacy benefit caps are associated with higher rates of medication discontinuation across the most common therapeutic classes and that only a minority of those who discontinue use reinitiate therapy once coverage resumes. Plan members who reach their cap are more likely than others to switch plans and increase their rate of generic use; however, in most cases, the shift is temporary. Given the similarities between these plans and Part D, we make some inferences about reforms for Medicare.Keywords
This publication has 6 references indexed in Scilit:
- Unintended Consequences of Caps on Medicare Drug BenefitsNew England Journal of Medicine, 2006
- Assessing The Impact Of Coverage Gaps In The Medicare Part D Drug BenefitHealth Affairs, 2005
- Cost-Lowering Strategies Used by Medicare Beneficiaries Who Exceed Drug Benefit Caps and Have a Gap in Drug CoverageJAMA, 2004
- Medicare Beneficiaries??? Management of Capped Prescription BenefitsMedical Care, 2001
- Effects of Limiting Medicaid Drug-Reimbursement Benefits on the Use of Psychotropic Agents and Acute Mental Health Services by Patients with SchizophreniaNew England Journal of Medicine, 1994
- Longitudinal data analysis using generalized linear modelsBiometrika, 1986